Delivery Order SPE2DB24D1205-SPE2DB24FCSLP
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,974.30 firm fixed-price contract provides for the delivery of 180 mg vials of the drug TRODELVY. The contract has an ultimate completion date of April 2, 2025 and was awarded on March 12, 2025. This order is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a $12,014 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 180 mg vials of the drug TRODELVY. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide....
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the supply of TRODELVY 180 MG VIALS, a pharmaceutical product, with a ceiling value of $12,779.44 and a completion date of August 7, 2025. The contract is a firm fixed-price delivery order, and it is not a set-aside contract. AmerisourceBergen Drug Corp has an Indefinite Delivery...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. The contract, valued at $6,007.00, is for the delivery of 180 mg vials of the drug TRODELVY to a location in Conshohocken, Pennsylvania by March 15, 2024. There is no set-aside designation for this contract. AmerisourceBergen Drug Corp holds an indefinite delivery contract with a...
- This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the Department of Defense. The $4,505.25 firm fixed price contract is for the delivery of 180 mg vials of the pharmaceutical product TRODELVY. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of 180 mg vials of the drug TRODELVY, with a ceiling value of $12,014.00 and a performance period through April 18, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $6,007.00 firm fixed price order is for the supply of TRODELVY 180 MG VIALS to support military treatment programs and facilities. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 180 mg vials of the pharmaceutical drug TRODELVY. The contract has a ceiling value of $18,021.00 and a period of performance through April 29, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRODELVY 180 MG VIALS, with a ceiling value of $6,389.72 and a completion date of July 15, 2025. This is a firm fixed-price delivery order contract, which is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of 180 mg vials of the drug TRODELVY. The order has a potential value of $6,007.00 and a performance period through March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB24FCSLPDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The award, valued at $6,007.00, is for the provision of 180 mg vials of the pharmaceutical drug TRODELVY. This is a firm fixed-price contract with a period of performance ending on July 24, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, is the prime contractor for this award. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, to deliver a range of pharmaceutical products and medical supplies to support the Department of Defense worldwide. This specific delivery order falls under the larger IDC framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 7/2/24 |